Help us create more content like this
Already a member? Sign in.
Sign up to our newsletter to get the latest updates and events from the leading Afro-Diaspora publisher straight to your inbox.
After 44 days, Kendric Cromer, the world’s first sickle cell patient to start commercially licensed gene therapy, was finally discharged from the hospital last Wednesday. One study estimates that approximately 100,000 people in the United States suffer from sickle cell disease, with Black people making up a large percentage of those affected. The 12-year-old Washington…
Already a member? Sign in.
Already a member? Sign in.
Sign up to our newsletter to get the latest updates and events from the leading Afro-Diaspora publisher straight to your inbox, plus our curated weekly brief with top stories across our platforms.
No, Thank You